News
Radiant Biotherapeutics, a Canadian biotech advancing multi-specific, multi-affinity antibody (Multabody) therapeutics in ...
Dutch privately held Amarna Therapeutics, which specializes in transformative gene therapies announced the formalization of ...
Shares of US biopharma Rhythm Pharmaceuticals rose 27.4% to $82.96 in early trading today, as it announced positive top-line ...
The US Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for ...
US clinical-stage biotech ProKidney reported statistically-significant and clinically-meaningful positive top-line results ...
US antivirals specialist Gilead Sciences today announced a strategic partnership agreement with the Global Fund to Fight AIDS ...
New Jersey, USA-headquartered Champions Oncology, a translational oncology research organization, yesterday announced the ...
Japan’s JCR Pharmaceuticals (TYO: 4552) closed 15% higher after Wednesday’s trading, as it signed a new licensing deal.
US pharma giant Merck & Co today revealed it has made a bid to acquire UK-based lung therapy company Verona Pharma, sending ...
Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...
French biotech Ciloa is joining the race to treat type 2 diabetes and obesity, armed with 6.5 million euros ($7.6 million) in ...
A new analysis from US data analytics firm Phesi has raised concerns about the viability of ongoing Phase III trials in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results